IL313729A - Gap junction modulators and their use for the treatment of age-related macular degeneration - Google Patents
Gap junction modulators and their use for the treatment of age-related macular degenerationInfo
- Publication number
- IL313729A IL313729A IL313729A IL31372924A IL313729A IL 313729 A IL313729 A IL 313729A IL 313729 A IL313729 A IL 313729A IL 31372924 A IL31372924 A IL 31372924A IL 313729 A IL313729 A IL 313729A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- treatment
- prevention according
- amd
- retinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292783P | 2021-12-22 | 2021-12-22 | |
| PCT/EP2022/087342 WO2023118366A1 (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL313729A true IL313729A (en) | 2024-08-01 |
Family
ID=84981302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL313729A IL313729A (en) | 2021-12-22 | 2022-12-21 | Gap junction modulators and their use for the treatment of age-related macular degeneration |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250018002A1 (https=) |
| EP (1) | EP4452260B1 (https=) |
| JP (1) | JP2025500123A (https=) |
| CN (1) | CN118450892A (https=) |
| CA (1) | CA3240515A1 (https=) |
| DK (1) | DK4452260T3 (https=) |
| FI (1) | FI4452260T3 (https=) |
| IL (1) | IL313729A (https=) |
| WO (1) | WO2023118366A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202310195D0 (en) * | 2023-07-03 | 2023-08-16 | Hastings Nataly | Method for mitigating symptoms of neurological condition and a system therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6259296A (ja) | 1985-09-10 | 1987-03-14 | Green Cross Corp:The | ペプタイド誘導体 |
| IL157447A0 (en) | 2001-02-22 | 2004-03-28 | Zealand Pharma As Zealand Phar | New medical uses of intercellular communication facilitating compounds |
| UA96283C2 (uk) | 2005-12-23 | 2011-10-25 | Зіланд Фарма А/С | Модифіковані міметики лізину |
| PL2468724T3 (pl) | 2006-12-21 | 2016-05-31 | Zealand Pharma As | Synteza związków pirolidynowych |
| JP6989864B2 (ja) * | 2017-05-05 | 2022-02-03 | ジーランド ファーマ，アー／エス | ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用 |
-
2022
- 2022-12-21 CN CN202280084727.5A patent/CN118450892A/zh active Pending
- 2022-12-21 IL IL313729A patent/IL313729A/en unknown
- 2022-12-21 US US18/708,367 patent/US20250018002A1/en active Pending
- 2022-12-21 CA CA3240515A patent/CA3240515A1/en active Pending
- 2022-12-21 WO PCT/EP2022/087342 patent/WO2023118366A1/en not_active Ceased
- 2022-12-21 DK DK22843707.5T patent/DK4452260T3/da active
- 2022-12-21 FI FIEP22843707.5T patent/FI4452260T3/fi active
- 2022-12-21 EP EP22843707.5A patent/EP4452260B1/en active Active
- 2022-12-21 JP JP2024529338A patent/JP2025500123A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118366A1 (en) | 2023-06-29 |
| CA3240515A1 (en) | 2023-06-29 |
| US20250018002A1 (en) | 2025-01-16 |
| EP4452260B1 (en) | 2026-01-28 |
| EP4452260A1 (en) | 2024-10-30 |
| JP2025500123A (ja) | 2025-01-09 |
| FI4452260T3 (fi) | 2026-03-30 |
| CN118450892A (zh) | 2024-08-06 |
| DK4452260T3 (da) | 2026-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10799552B2 (en) | Methods for treating diabetic neurotherapy | |
| Li et al. | A small molecule inhibitor of VE-PTP activates Tie2 in Schlemm's canal increasing outflow facility and reducing intraocular pressure | |
| CA2671613C (en) | Methods of use of trk receptor modulators | |
| Andrés-Guerrero et al. | Targeting Schlemm’s canal in the medical therapy of glaucoma: current and future considerations | |
| JP2018521120A (ja) | 翼状片を治療するための組成物及び方法 | |
| US20140024598A1 (en) | Methods and compositions for preserving retinal ganglion cells | |
| US20220031800A1 (en) | Peptides for treating non-exudative macular degeneration and other disorders of the eye | |
| US20220133866A1 (en) | Method for the Treatment of a Disease Using Pigment Epithelium-Derived Factor (PEDF) | |
| EP4452260B1 (en) | Gap junction modulators and their use for the treatment of age-related macular degeneration | |
| US11324799B2 (en) | Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease | |
| US20230338483A1 (en) | Method for the treatment of a disease using pigment epithelium-derived factor (pedf) | |
| EA051681B1 (ru) | Модуляторы щелевых контактов и их применение для лечения возрастной макулярной дегенерации | |
| US20220280473A1 (en) | Compositions and methods for modulating epithelial-mesenchymal transition | |
| JP7795359B2 (ja) | 上皮および関門の完全性を保護するための組成物および方法 | |
| US10973867B2 (en) | Compositions and methods for treating retinopathy | |
| Thakur | Retinal delivery of steroidal and non-steroidal drugs for the treatment of back of the eye disorders |